
Scapa (SCPA) will legally contest medical technology group ConvaTec’s (CTEC) decision to exit a “material” supply deal worth $30m (£23.8m) in annual revenues.
Scapa (SCPA) will legally contest medical technology group ConvaTec’s (CTEC) decision to exit a “material” supply deal worth $30m (£23.8m) in annual revenues.
Full access for just £3.37 a week:
• Tips and recommendations - to beat the market
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office